Big Sur Wealth Management LLC Gilead Sciences, Inc. Transaction History

Big Sur Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$67.69 - $73.03 $261,960 - $282,626	-3,870 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $22,977 - $28,889	370 Added 10.57%	3,870 $245,000
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $26,765 - $31,080	-370 Reduced 9.56%	3,500 $269,000
Q4 2019 Jan 30, 2020	SELL	$61.62 - $67.78 $49,296 - $54,224	-800 Reduced 17.13%	3,870 $251,000
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $35,640 - $39,460	-500 Reduced 9.67%	4,670 $361,000
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $26,950 - $32,856	370 Added 7.71%	5,170 $390,000
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $341,520 - $400,896	4,800	4,800 $344,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Big Sur Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Big Sur Wealth Management LLC with notifications on news.